Orginal ContributionSignaling through the vascular endothelial growth factor receptor VEGFR-2 protects hippocampal neurons from mitochondrial dysfunction and oxidative stress
Introduction
Oxidative stress and mitochondrial dysfunction contribute to the pathogenesis of a number of neurodegenerative disorders including Alzheimer's and Parkinsonʼs disease [1]. One approach for protecting neurons from oxidative insults is to administer neurotrophic growth factors. One such factor is VEGF (VEGF-A or VEGF165) which is a mitogen that stimulates angiogenesis and neuroprotection through autocrine or paracrine mechanisms [2], [3]. In addition, VEGF can stimulate axonal outgrowth, and rescue rat mesencephalic neurons or hippocampal cells from death induced by serum withdrawal, ischemia, hypoxia, and glutamate-induced toxicity [4], [5], [6] and elicit neuroprotection via angiogenesis and neurogenesis [7], [8], [9]. Delineating this neuroprotective mechanism is complex since VEGF can undergo cell-surface interactions with different cognate tyrosine kinase receptors such as VEGFR-1, VEGFR-2, and the non-tyrosine kinase members of the neuropilin family of class 3 semaphorin receptors Neuropilin-1 and -2 (NP-1, NP-2) receptors [10]. While VEGF mediates most biological effects through VEGFR-2, it can interact with NP-1 as a coreceptor that enhances VEGF signaling. Ligand binding to VEGFR-1 and VEGFR-2 results in receptor dimerization followed by autophosphorylation and activation of downstream signaling cascades [3]. In neurons, NP-1 is a cell-surface receptor for both VEGF and class 3 semaphorins and plays a functional role in axonal pathfinding, retraction, and collapse during development. While the function of VEGFR-1 remains unclear, it is implicated as a decoy receptor that sequesters VEGF from activating VEGFR-2. VEGF-B, which is a ligand for VEGFR-1 but not VEGFR-2, is poorly angiogenic in the brain but can protect against mitochondrial membrane permeabilization [11], proapoptotic gene expression [12], and is coexpressed with genes encoding mitochondrial proteins [13]. Thus, VEGF-B may protect against mitochondrial dysfunction independent of angiogenesis.
Oxidative insults are implicated as causative factors of neuronal damage in several different neurological disorders and increasing evidence from in vitro and in vivo studies shows that VEGF signaling protects neurons from insults which are known to induce oxidative stress [14], [15]. In this context, VEGF overexpression has been shown to delay the onset of neuronal death in an animal model of amyotrophic lateral sclerosis (ALS) where oxidative stress is a contributing factor [16]. VEGF has been shown to mediate neuroprotection under stress conditions through the downstream activation of the phosphatidylinositol 3-kinase (PI3K)/Akt and mitogen-activated protein kinase MEK/ERK1/2 pathways [6], [17], [18], [19] and by suppressing caspase activation [20]. While several of these studies show that VEGF activates VEGFR-2 to mediate survival, the protective capacity of VEGFR-2 signaling remains unclear. Therefore, the aim of these studies is to determine the impact of VEGFR-2 signaling on the survival of mature hippocampal neurons by blocking its activation using pharmacological and gene silencing methods.
In previous studies we used a neuronal model of serum-deprived SK-N-SH cells to show that VEGF signaling through VEGFR-2 prevents a caspase-dependent cell death [21]. Therefore, we addressed whether VEGF signaling through VEGFR-2 protected rat hippocampal neurons from the harmful effects of nutritional stress. Depriving cultured neurons from vital nutrients provide a viable model to identify the molecular basis of neuronal insults that would occur under pathological conditions in vivo. Our findings show that a blockade of VEGFR-2 function in hippocampal neurons leads to a rapid loss in viability that is manifested by induction of markers of oxidative stress, mitochondrial dysfunction, and a loss in the activation of prosurvival pathways. Notably, the inclusion of exogenous VEGF or VEGF-B mediates a time-dependent rescue from this response, suggesting that a molecular switch to an alternate receptor can provide neuroprotection when VEGFR-2 activity is blocked. Our findings establish a link between VEGFR-2 signaling and mitochondrial function in differentiated rat neurons and provide insight on oxidative stress-related pathways that mediate neuronal damage and how exogenous VEGF or VEGF-B may counteract these events.
Section snippets
Materials
Recombinant human vascular endothelial growth factor 165 (VEGF165) and VEGF-B were obtained from PeproTech Inc (Rocky Hill, NJ). The inhibitors of VEGFR-2 (SU1498) and PI3K/Akt (Wortmannin) were obtained from EMD Biosciences Inc. (San Diego, CA). The inhibitor of MEK1/2 (U0126) was obtained from Promega Corporation (Madison, WI). The antioxidant N-acetylcysteine (NAC) was purchased from Sigma-Aldrich (St. Louis, MO).
Primary cell culture and treatments
All animal studies were performed in accordance with the National Institutes of
VEGFR-2 signals survival in mature hippocampal neurons
We showed previously that VEGFR-2 elicits neuroprotection in serum-starved neuroblastoma cells through autocrine and paracrine mechanisms and a blockade of receptor function leads to a loss in cell viability [21], [25]. Whether VEGFR-2 plays a similar role in primary cultures of mature hippocampal neurons remains unclear. In these studies, we hypothesized that VEGF signaling through VEGFR-2 alone plays a significant role in protecting mature hippocampal neurons from oxidative stress induced by
Discussion
In this study we examined the effects of VEGFR-2 inhibition on the survival of nutritionally deprived hippocampal neurons. We found that neuronal viability was reduced only slightly in NB cultured neurons when compared to those cultured in NB supplemented with B27 and survival under both conditions was enhanced by the inclusion of exogenous VEGF and inhibited by VEGFR-2 inhibition. We attribute survival without B27 to an autocrine signaling by endogenous VEGF through VEGFR-2 based on the
Conclusions
In conclusion, we show that a blockade of VEGFR-2 function by pharmacological inhibition or gene silencing triggers oxidative stress and mitochondrial dysfunction in mature hippocampal neurons. These events are manifested by an induction of HO-1, caspase-3 cleavage with a parallel loss in both cell viability and the activation of prosurvival Akt and ERK1/2. These findings also implicate activated BAD and decreased Bcl-xL levels as participants in the mitochondrial dysfunction and oxidative
Acknowledgments
This investigation was funded by a grant from the National Center for Research Resources [RR003037], a component of the National Institutes of Health (NIH), and a NINDS/NIH grant [SC1NS066033]. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NCRR or NIH.
References (54)
- et al.
Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system
J. Biol. Chem.
(2002) - et al.
The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis
Trends Cardiovasc. Med
(2002) - et al.
Induction of vascular endothelial growth factor receptors and phosphatidylinositol 3′-kinase/Akt signaling by global cerebral ischemia in the rat
Neuroscience
(2000) - et al.
Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor
Neuroscience
(2001) - et al.
Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium
Cell Signal.
(2004) - et al.
Crosstalk between VEGFR2 and muscarinic receptors regulates the mTOR pathway in serum starved SK-N-SH human neuroblastoma cells
Cell Signal
(2011) - et al.
Reduction of a vascular endothelial growth factor receptor, fetal liver kinase-1, by antisense oligonucleotides induces motor neuron death in rat spinal cord exposed to hypoxia
Neuroscience
(2005) - et al.
p90(RSK) blocks bad-mediated cell death via a protein kinase C-dependent pathway
J. Biol. Chem.
(1999) - et al.
Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A
Mol. Cell
(1999) - et al.
Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress
J. Biol. Chem.
(2007)
The homeostasis of iron and suppression of HO-1 involved in the protective effects of nimodipine on neurodegeneration induced by aluminum overloading in mice
Eur. J. Pharmacol
Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinsonʼs disease
Mol. Neurodegener
VEGFR1 (Flt-1+/-) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardium
Free Radic. Biol. Med.
Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein
J. Biol. Chem
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
Nature
Role and therapeutic potential of VEGF in the nervous system
Physiol. Rev.
Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades
FASEB J
Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia
Proc. Natl. Acad. Sci. USA
Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt
J. Neurosci.
Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo
Proc. Natl. Acad. Sci. USA
VEGF links hippocampal activity with neurogenesis, learning and memory
Nature Genet.
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
J. Clin. Invest.
Neuronal FLT1 receptor and its selective ligand VEGF-B protect against retrograde degeneration of sensory neurons
FASEB J
VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats
J. Clin. Invest.
Vascular endothelial growth factor B controls endothelial fatty acid uptake
Nature
Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential
Neuro-Signals
VEGF: a critical player in neurodegeneration
J. Clin. Invest.
Cited by (26)
The VEGFs/VEGFRs system in Alzheimer's and Parkinson's diseases: Pathophysiological roles and therapeutic implications
2024, Pharmacological ResearchChronic VEGFR-3 signaling preserves dendritic arborization and sensitization under stress
2021, Brain, Behavior, and ImmunityCitation Excerpt :These “vasculogenic” factors have been shown to drive adult neurogenesis and display neuroprotective and pro-survival properties in retinal ganglionic injury, stroke, and motor neuron injury models (Mauceri et al., 2020; Froger et al., 2020; Harde, et al., 2019). For example, signaling of VEGFR-2 (Hao and Rockwell, 2013), the most well-characterized angiogenic pathway, regulates neuronal branching and neuroprotection signaling via the canonical Akt and ERK signaling pathways (Hu et al., 2005). While the “lymphangiogenic” factors, VEGF-C and VEGF-D, have been less well characterized in this context, convincing data demonstrate that VEGF-C and/or VEGFR-3 signaling drive enhanced neurogenesis in young NSCs and serve as a critical dendritic arborization maintenance factors in mouse hippocampal neurons (Han et al., 2015; Mauceri et al., 2011).
Neuroprotective effects of glial mediators in interactions between retinal neurons and Müller cells: RGC-Müller cell communication
2021, Experimental Eye ResearchCitation Excerpt :Bcl-xL, the predominant anti-apoptotic protein in the retina (Levin et al., 1997), is involved in resistance to hypoxic injury and apoptotic cell death (Dong et al., 2004). Given that the anti-apoptotic action of VEGF has been linked to an increased Bcl-2 and Bcl-xL expression in neuronal cells (Sánchez et al., 2010; Hao and Rockwell, 2013), it is conceivable that hypoxia-induced increasing VEGF levels (Fig. 2d, g, Fig. 3b) contribute to upregulation of Bcl-2 and Bcl-xL (Fig. 4a and b). Fine-tuning of Bcl-2/Bad or Bcl-xL/Bad expression ratios seems to be important for the viability status of RGCs.
Intracavernous Injection of Autologous Platelet-Rich Plasma Ameliorates Hyperlipidemia-Associated Erectile Dysfunction in a Rat Model
2021, Sexual MedicineCitation Excerpt :BDNF-induced mitophagy plays a protective role against endothelial cell damage in hyperglycemic conditions.29 VEGF promotes signaling through an alternate VEGF receptor-2 in the setting of mitochondrial dysfunction and oxidative stress.30 From this previous study, it is logical to conclude that the beneficial histological and functional results of PRP treatment are derived from the PRP-mediated delivery of IGF-1, BDNF, and VEGF.
PI3K/Akt signaling pathway and Hsp70 activate in hippocampus of rats with chronic manganese sulfate exposure
2018, Journal of Trace Elements in Medicine and BiologyCitation Excerpt :At the same time, decreased anti-oxidant enzyme activity prevents excessive free radicals in the body to be eliminated in time, increases lipid peroxidation, and eventually results in mitochondrial dysfunction and disruption of energy production. The PI3K/Akt signaling pathway is commonly activated after oxidative stress injury, and it plays an important role in protecting against nerve cell death [43]. A previous study found that Foxo3a-siRNA significantly inhibited phospho-Foxo3a expression, resulting in the suppression of peroxiredeoxin III protein expression, and FoxO3a can protect nerve cells from oxidative stress by regulating antioxidant enzymes [44].